ContraFect Corp
OTC:CFRXQ
ContraFect Corp
OTC:CFRXQ
Price:
0
USD
Market Cap:
$0
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ContraFect Corp
OTC:CFRXQ
|
US |
|
Iodm Ltd
ASX:IOD
|
AU |
|
P
|
Padmalaya Telefilms Ltd
BSE:532350
|
IN |
|
Torian Resources Ltd
ASX:TNR
|
AU |
|
E
|
eXeBlock Technology Corp
CNSX:XBLK.X
|
CA |
|
G
|
Guangzhou Devotion Thermal Technology Co Ltd
SZSE:300335
|
CN |
|
M
|
Matba Rofex SA
BCBA:MTR
|
AR |
|
Dynamic Group Holdings Ltd
ASX:DDB
|
AU |
|
C
|
China Ever Grand Financial Leasing Group Co Ltd
HKEX:379
|
HK |
|
Q
|
Quantong Holdings Ltd
HKEX:8316
|
HK |
|
K
|
Komo Plant Based Foods Inc
CNSX:YUM
|
CA |
|
Goldlok Holdings Guangdong Co Ltd
SZSE:002348
|
CN |
|
Antilles Gold Ltd
ASX:AAU
|
AU |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of CFRXQ.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CFRXQ
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
CFRXQ Competitors Multiples
ContraFect Corp Competitors
ContraFect Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
ContraFect Corp
OTC:CFRXQ
|
107 USD | 0 | -0 | 0.2 | 0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD | 5.9 | 86.7 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.6 | 17.7 | 13.2 | 15 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3 | 33.2 | 11.2 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.3 | 36.2 | 39.4 | 40.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
